DUPILUMAB TREATMENT LEADS TO SUSTAINED REDUCTIONS IN ORAL CORTICOSTEROID USE IN PATIENTS WITH ORAL CORTICOSTEROID-DEPENDENT SEVERE ASTHMA

Autor: MARK GURNELL, CHRISTIAN C DOMINGO, KLAUS F RABE, ANDREW MENZIES-GOW, DAVID B PRICE, GUY G BRUSSELLE, MICHAEL E WECHSLER, CHANGMING XIA, NAMI PANDIT-ABID, REBECCA GALL, JUBY A JACOB-NARA, PAUL J ROWE, YAMO DENIZ, SHAHID SIDDIQUI

Publikováno v: Chest. 162:A1909-A1913

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1ad2f600174803bcdd1b824e31edd369
https://doi.org/10.1016/j.chest.2022.08.1587

Cough severity visual analog scale scores and quality of life in patients with refractory or unexplained chronic cough.

Autor: Domingo C; Servicio de Neumología, Corporació Sanitària Parc Taulí, Parc Taulí, 1, Sabadell, 08208, Barcelona, Spain; Departamento de Medicina, Universitat Autònoma de Barcelona, Plaça Cívica, Bellaterra, 08193, Barcelona, Spain., Quirce S; Servicio de Alergia, Hospital Universitario La Paz, P.° de La Castellana, 261, Fuencarral-El Pardo, 28046, Madrid, Spain., Dávila I; Servicio de Alergia, Hospital Universitario de Salamanca, Departamento de Ciencias Biomédicas y del Diagnóstico, P.° de San Vicente, 182, 37007, Salamanca, Spain; Facultad de Medicina, Universidad de Salamanca, C. Alfonso X El Sabio, S/n, 37007, Salamanca, Spain., Crespo-Lessman A; Servicio de Neumología y Alergia, Hospital de La Santa Creu I Sant Pau, Sant Antoni Maria Claret, 167, 08025, Barcelona, Spain., Arismendi E; Servicio de Neumología, Hospital Clínic de Barcelona, C. de Villarroel, 170, L'Eixample, 08036, Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERES), Instituto de Salud Carlos III, C/ Monforte de Lemos 3-5, Pabellón 11. Planta 0, 28029, Madrid, Spain; IDIBAPS, Universitat de Barcelona, Gran Via de Les Corts Catalanes, 585, 08007, Barcelona, Spain., De Diego A; Servicio de Neumología, Hospital Universitari I Politècnic La Fe, Fernando Abril Martorell, 106, 46026, Valencia, Spain., González-Barcala FJ; Grupo de Investigación Traslacional en Enfermedades de Las Vías Aéreas (TRIAD), Santiago de Compostela, Spain; Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Hospital Clínico, Edificio D, 1(a) Planta. Travesía da Choupana S/N, 15706, Santiago de Compostela, Spain; Departamento de Medicina, Universidad de Santiago de Compostela, Rúa de San Francisco, A Coruña, s/n, 15782, Santiago de Compostela, Spain; Departamento de Medicina Respiratoria, Hospital Universitario de Santiago de Compostela, Rúa da Choupana, A Coruña, S/n, 15706, Santiago de Compostela, Spain., Pérez de Llano L; Servicio de Neumología, Hospital Lucus Augusti, Rúa Dr. Ulises Romero, 1, 27003, Lugo, Spain., Cea-Calvo L; Medical Affairs, MSD, C. de Josefa Valcárcel, 38, 28027, Madrid, Spain. Electronic address: luis_cea@merck.com., Sánchez-Jareño M; Medical Affairs, MSD, C. de Josefa Valcárcel, 38, 28027, Madrid, Spain., López-Cotarelo P; Medical Affairs, MSD, C. de Josefa Valcárcel, 38, 28027, Madrid, Spain., Puente-Maestu L; Servicio de Neumología, Hospital Universitario Gregorio Marañón, UCM, C. del Dr. Esquerdo, 46, Retiro, 28007, Madrid, Spain.

Publikováno v: Respiratory investigation [Respir Investig] 2024 Aug 27; Vol. 62 (6), pp. 987-994. Date of Electronic Publication: 2024 Aug 27.

Tezepelumab in patients with allergic and eosinophilic asthma.

Autor: Caminati M; Asthma Center and Allergy Unit, Verona Integrated University Hospital & Department of Medicine, University of Verona, Verona, Italy., Buhl R; Pulmonary Department, Mainz University Hospital, Mainz, Germany., Corren J; David Geffen School of Medicine, University of California, Los Angeles, California, USA., Hanania NA; Section of Pulmonary and Critical Care Medicine, Baylor College of Medicine, Houston, Texas, USA., Kim H; Department of Medicine, Western University, London, Ontario, Canada.; Department of Medicine, McMaster University, Hamilton, Ontario, Canada., Korn S; IKF Pneumologie Mainz, Mainz, Germany.; Thoraxklinik Heidelberg, Heidelberg, Germany., Lommatzsch M; Department of Pneumology and Critical Care Medicine, University of Rostock, Rostock, Germany., Martin N; Respiratory and Immunology, BioPharmaceuticals Medical, AstraZeneca, Cambridge, UK.; University of Leicester, Leicester, UK., Matucci A; Immunoallergology Unit, Careggi University Hospital, Florence, Italy., Nasser SM; Department of Allergy, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Pavord ID; Respiratory Medicine, NIHR Oxford Biomedical Research Centre, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Domingo C; Servei de Pneumologia, Corporació Sanitària Parc Taulí, Sabadell, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.

Publikováno v: Allergy [Allergy] 2024 May; Vol. 79 (5), pp. 1134-1145. Date of Electronic Publication: 2023 Dec 26.

Impact of dupilumab across seasons in patients with type 2, uncontrolled, moderate-to-severe asthma.

Autor: Peters AT; Departments of Medicine and Otolaryngology Head & Neck Surgery, Northwestern University Feinberg School of Medicine, Chicago, Illinois. Electronic address: anjupeters@northwestern.edu., Sagara H; Division of Respiratory Medicine and Allergology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan., Corren J; David Geffen School of Medicine at UCLA, Los Angeles, California., Domingo C; Pulmonary Service, Corporació Sanitària Parc Taulí, Sabadell, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain., Altincatal A; Sanofi, Cambridge, Massachusetts., Soler X; Regeneron Pharmaceuticals Inc., Tarrytown, New York., Pandit-Abid N; Sanofi, Bridgewater, New Jersey., Crikelair N; Regeneron Pharmaceuticals Inc., Tarrytown, New York., Rowe PJ; Sanofi, Bridgewater, New Jersey., Jacob-Nara JA; Sanofi, Bridgewater, New Jersey., Deniz Y; Regeneron Pharmaceuticals Inc., Tarrytown, New York.

Publikováno v: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology [Ann Allergy Asthma Immunol] 2024 Apr; Vol. 132 (4), pp. 477-484.e4. Date of Electronic Publication: 2023 Nov 25.

Diagnosed and undiagnosed cough-related stress urinary incontinence in women with refractory or unexplained chronic cough: Its impact on general health status and quality of life.

Autor: Arismendi E; Servicio de Neumología, Hospital Clínic de Barcelona, Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERES), Instituto de Salud Carlos III, Barcelona, IDIBAPS, Universitat de Barcelona, Barcelona, Spain., Puente-Maestu L; Servicio de Neumología, Facultad de Medicina de la UCM, Hospital Universitario Gregorio Marañón, Madrid, Spain., Domingo C; Servicio de Neumología, Hospital Parc Taulí, Sabadell. Departamento de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain., Dávila I; Servicio de Alergia, Hospital Universitario de Salamanca, Departamento de Ciencias Biomédicas y del Diagnóstico, Facultad de Medicina, Universidad de Salamanca, Salamanca, Spain., Quirce S; Servicio de Alergia, IdiPAZ, CIBER de Enfermedades Respiratorias (CIBERES), Hospital Universitario La Paz, Madrid, Spain., González-Barcala FJ; Grupo de Investigación Traslacional en Enfermedades de las Vías Aéreas (TRIAD), Santiago de Compostela, Spain; Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Santiago de Compostela, Spain; Complejo Hospitalario Universitario de Santiago de Compostela (CHUS), Universidad de Santiago de Compostela (USC), Santiago de Compostela, Spain.; Departamento de Medicina Respiratoria, Hospital Universitario de Santiago de Compostela, Santiago de Compostela, Spain., Crespo-Lessmann A; Servicio de Neumología y Alergia, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., Sánchez-Jareño M; Medical Affairs, MSD, Madrid, Spain., Rivas-Pardinas C; Medical Affairs, MSD, Madrid, Spain., Cea-Calvo L; Medical Affairs, MSD, Madrid, Spain.

Publikováno v: Chronic respiratory disease [Chron Respir Dis] 2024 Jan-Dec; Vol. 21, pp. 14799731241273751.